• Citer

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

par Pivot, X;Awada, Ahmad ;Gedouin, D;Kerger, Joseph ;Rolland, Florence ;Cupissol, Didier;Caponigro, F;Comella, G;Lopez-Pousa, J J;Guardiola, E;Giroux, B;Gérard, B.;Schneider, M
Référence Annals of oncology, 14, 3, page (373-377)
Publication Publié, 2003-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
Auteur:	Pivot, X; Awada, Ahmad; Gedouin, D; Kerger, Joseph; Rolland, Florence; Cupissol, Didier; Caponigro, F; Comella, G; Lopez-Pousa, J J; Guardiola, E; Giroux, B; Gérard, B.; Schneider, M
Informations sur la publication:	Annals of oncology, 14, 3, page (373-377)
Statut de publication:	Publié, 2003-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antimetabolites, Antineoplastic -- administration & dosage
	Antimetabolites, Antineoplastic -- adverse effects
	Antimetabolites, Antineoplastic -- therapeutic use
	Carbazoles -- administration & dosage
	Carbazoles -- adverse effects
	Carbazoles -- therapeutic use
	Disease Progression
	Drug Administration Schedule
	Edema -- etiology
	Female
	Head and Neck Neoplasms -- drug therapy
	Head and Neck Neoplasms -- pathology
	Humans
	Infusions, Intravenous
	Injections, Intravenous
	Male
	Methotrexate -- administration & dosage
	Methotrexate -- adverse effects
	Methotrexate -- therapeutic use
	Middle Aged
	Neoplasm Recurrence, Local -- drug therapy
	Neoplasm Recurrence, Local -- pathology
	Pyridines -- administration & dosage
	Pyridines -- adverse effects
	Pyridines -- therapeutic use
	Survival Analysis
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:pmid/12598340